* Cosmos Health Inc COSM.OQ reported a quarterly adjusted
loss
of $1.73 per share for the quarter ended in January. The lone
analyst forecast for the quarter was for a loss of 20 cents per
share.
* Revenue was $15.84 million; analysts expected $13.75
million.
* Cosmos Health Inc's reported EPS for the quarter was a
loss of
$1.73.
* The company reported a quarterly loss of $20.98 million.
* Cosmos Health Inc shares had risen by 9.6% this
quarter and
lost 19.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Cosmos Health Inc
is $4.00
This summary was machine generated from LSEG data August 5 at
11:20 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.20 -1.73 Missed